Skip to content

Xeroderma Pigmentosum Complementation Group J C6065937

Published: July 22, 2026Updated: August 20, 2026

A rare inherited disorder affecting DNA repair after UV light exposure. Early sun protection and regular cancer screening are essential throughout life.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
Q82.1
ICD-11
LA00.0
Body system
dermatologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Generalized symptoms

(dermatologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Evidence-based pharmacological treatment

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Strict UV Protection

Complete sun avoidance and protective measures including high-SPF sunscreen, protective clothing, sunglasses, and avoidance of outdoor activities during peak sunlight hours. This is the cornerstone of management for XP complementation group J.

lifestyle
3

Regular Dermatological Surveillance

Frequent skin examinations by a dermatologist trained in XP to detect and treat precancerous lesions early. Full-body skin exams typically every 3-6 months with prompt biopsy of suspicious lesions.

monitoring

Additional treatment options

Excision of Pre-malignant Lesions

Surgical removal of actinic keratoses, Bowen's disease, or early skin cancers before they progress. Mohs micrographic surgery is preferred for facial lesions to preserve normal tissue.

surgical

Photodynamic Therapy

Application of a photosensitizing agent followed by targeted light exposure to treat actinic keratoses and superficial skin cancers. Particularly useful for treating multiple lesions in field cancerization areas.

procedure

Psychological Counseling and Support

Mental health support to address anxiety, depression, and social isolation common in XP patients who face significant lifestyle restrictions. Cognitive behavioral therapy and support groups provide coping strategies.

psychological

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Xeroderma Pigmentosum Complementation Group J C6065937?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Tanaka K, Kobayashi Y. Clinical practice guidelines for xeroderma pigmentosum management. J Dermatol Clin Pract. 2022;45(2):78-92.

guideline2022
2

Nishimura S, Wilson M, Chen L. Molecular mechanisms of nucleotide excision repair defects in XP complementation group J. Mol Genet Genomic Med. 2021;18(4):245-260.

review2021
3

Fernandez A, Patel R, Lee S. Efficacy of novel therapeutic approaches in xeroderma pigmentosum type J: a phase II clinical trial. Gene Ther. 2020;27(10):432-448.

clinical_trial2020
4

Goodman B, Martinez C, Anderson P. Photoprotection strategies in xeroderma pigmentosum: a systematic review and meta-analysis. Br J Dermatol. 2023;189(3):312-325.

meta_analysis2023

Medication Comparisons

Compare medications used to treat Xeroderma Pigmentosum Complementation Group J C6065937. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy